إعلان
إعلان
ELV
Elevance Health, Inc.
372.83
USDبرعاية
-1.96
-0.52%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
373.00
+0.17
+0.05%
تقارير أرباح ELV
النسبة الإيجابية المفاجئة
ELV تفوق 29 من 39 آخر التقديرات.
74%
التقرير التالي
بيانات التقرير القادم
٢٨ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$50.31B
/$3.18
التغير الضمني من Q3 25 (Revenue/ EPS)
+0.45%
/-47.26%
التغير الضمني من Q4 24 (Revenue/ EPS)
+11.84%
/-17.19%
Elevance Health, Inc. earnings per share and revenue
On ٢١ أكتوبر ٢٠٢٥, ELV reported earnings of 6.03 USD per share (EPS) for Q3 25, beating the estimate of 4.98 USD, resulting in a 21.02% surprise. Revenue reached 50.09 مليار, compared to an expected 49.86 مليار, with a 0.45% difference. The market reacted with a -1.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 المحللين forecast an EPS of 3.18 USD, with revenue projected to reach 50.31 مليار USD, implying an نقصان of -47.26% EPS, and زيادة of 0.45% in Revenue from the last quarter.
الأسئلة الشائعة
What were Elevance Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Elevance Health, Inc. reported EPS of $6.03, beating estimates by 21.02%, and revenue of $50.09B, 0.45% above expectations.
How did the market react to Elevance Health, Inc.'s Q3 2025 earnings?
The stock price moved down -1.22%, changed from $354.07 before the earnings release to $349.75 the day after.
When is Elevance Health, Inc. expected to report next?
The next earning report is scheduled for ٢٨ يناير ٢٠٢٦.
What are the forecasts for Elevance Health, Inc.'s next earnings report?
Based on 22
المحللين, Elevance Health, Inc. is expected to report EPS of $3.18 and revenue of $50.31B for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان